Skip to content
Trial Eligibility
Menu

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

NCT04302025

This study is recruiting at 23 US sites in 15 states, according to its ClinicalTrials.gov record last updated .

Summary

This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that meet protocol-specified biomarker criteria.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Non-small Cell Lung Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Genentech, Inc.
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 3

  • University of California Los Angeles - Jonsson Comprehensive Cancer Center · Los Angeles, CA
  • The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange · Orange, CA
  • UC Davis Comprehensive Cancer Center · Sacramento, CA

Connecticut · 1

  • Yale Cancer Center · New Haven, CT

District of Columbia · 1

  • MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center) · Washington D.C., DC

Florida · 1

  • Moffitt Cancer Center · Tampa, FL

Illinois · 4

  • Northwestern University · Chicago, IL
  • Northwestern Medicine Cancer Center Kishwaukee · DeKalb, IL
  • Northwestern Medicine Cancer Center Delnor · Geneva, IL
  • Northwestern Medicine Cancer Center Warrenville · Warrenville, IL

Massachusetts · 1

  • Dana-Farber Cancer Institute · Boston, MA

Michigan · 1

  • University of Michigan · Ann Arbor, MI

Minnesota · 1

  • Mayo Clinic · Rochester, MN

Missouri · 2

  • Ellis Fischel Cancer Center · Columbia, MO
  • Siteman Cancer Center - Washington University Medical Campus · St Louis, MO

New Hampshire · 1

  • Dartmouth Hitchcock Medical Center · Lebanon, NH

New York · 3

  • Columbia University Medical Center · New York, NY
  • Laura and ISAAC Perlmutter Cancer Center at NYU Langone. · New York, NY
  • Memorial Sloan Kettering Cancer Center · New York, NY

Ohio · 1

  • Ohio State University · Columbus, OH

Tennessee · 1

  • Baptist Clinical Research Institute · Memphis, TN

Texas · 1

  • University of Texas MD Anderson Cancer Center · Houston, TX

Virginia · 1

  • Virginia Cancer Specialists (Fairfax) - USOR · Fairfax, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.